Clover Health Investments, Corp. - Class A Common stock (CLOV)
2.9945
-0.5255 (-14.93%)
NASDAQ · Last Trade: Nov 5th, 2:59 PM EST
Detailed Quote
Previous Close
3.520
Open
2.820
Bid
2.990
Ask
3.000
Day's Range
2.590 - 3.020
52 Week Range
2.120 - 4.870
Volume
20,246,669
Market Cap
267.13M
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
11,333,056
Chart
About Clover Health Investments, Corp. - Class A Common stock (CLOV)
Clover Health Investments Corp is a healthcare technology company focused on improving the health outcomes of Medicare beneficiaries. By utilizing its proprietary data-driven platform, Clover Health aims to enhance care delivery and streamline operations for its members, promoting preventive care and tailored health services. The company partners with healthcare providers to deliver more efficient and personalized care, ultimately seeking to reduce costs and improve patient satisfaction in the healthcare system. Through innovation and technology, Clover Health strives to make healthcare more accessible and effective for seniors across the United States. Read More
Shares of health insurance company Clover Health (NASDAQ:CLOV) fell 24.2% in the morning session after the company reported disappointing third-quarter financial results and cut its full-year profitability forecast. While the Medicare-focused company saw its revenue climb by 50.1% compared to the previous year, its earnings per share missed forecasts. Looking ahead, Clover Health lowered its full-year guidance for adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to a midpoint of $22.5 million, which was significantly below analysts' expectations and implied a reduction from previous forecasts. The company attributed the weaker outlook to higher-than-expected medical costs and increased healthcare usage trends among its members. This guidance overshadowed its revenue, which beat Wall Street's estimates, as investors focused on the pressure on future profitability.
Health insurance company Clover Health (NASDAQ:CLOV) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 50.1% year on year to $496.7 million. Its GAAP loss of $0.05 per share was $0.02 below analysts’ consensus estimates.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Health insurance company Clover Health (NASDAQ:CLOV) announced better-than-expected revenue in Q3 CY2025, with sales up 50.1% year on year to $496.7 million. Its GAAP loss of $0.05 per share was $0.02 below analysts’ consensus estimates.
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums).
That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around.
Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.
Rapid spending isn’t always a sign of progress.
Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.
On a day where the broader S&P 500 and Nasdaq Composite indices soared to new all-time record highs, the S&P 500 Healthcare sector presented a compelling, albeit nuanced, narrative of market leadership and resilience. While the overall market sentiment exuded robust optimism, the healthcare sector itself showcased a
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Over the past six months, Clover Health’s shares (currently trading at $2.63) have posted a disappointing 18.1% loss, well below the S&P 500’s 32.7% gain. This may have investors wondering how to approach the situation.
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.
Great things are happening to the stocks in this article.
They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
A cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 2.9% in the morning session after its wholly-owned subsidiary, Counterpart Health, announced a major upgrade to its AI-powered physician-enablement platform with the launch of a new ambient scribing solution.
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
